Blue Lake and CyanVac Publish Phase 1 Data for Intranasal COVID-19 Vaccine Candidate Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company, and its affiliate CyanVac LLC have announced the publication of the full Phase 1 clinical study data for…
Allurion Submits Final PMA Module to FDA Following Strong AUDACITY Study Results Allurion Technologies, Inc., a global leader in innovative, non-surgical weight loss solutions, announced it has officially submitted the final module of its Pre-Market Approval (PMA) application to the…
Miach Orthopaedics Completes Enrollment in BEAR MOON ACL Study Miach Orthopaedics, Inc., a medical device company revolutionizing anterior cruciate ligament (ACL) treatment, announced that patient enrollment is now complete for its pivotal BEAR MOON study. This major clinical trial compares…
Twist Bioscience Accelerates Express Delivery for All Gene Fragment Formats Twist Bioscience Corporation, a leading mid-cap growth and value equity company in the life sciences sector, has announced a significant enhancement to its synthetic DNA offering. Effective immediately, Twist is…
Lab-on-a-Chip and Microfluidics World Congress 2025 Set to Explore Next-Gen Diagnostics, 3D Bioprinting, and Commercialization The 18th Annual Lab-on-a-Chip & Microfluidics World Congress 2025, now officially included in the ResearchAndMarkets.com conference offering, is poised to once again bring together innovators,…
ICON Recognized Globally for Clinical Research Leadership, Innovation, and Sustainability in 2025 ICON plc , a global leader in healthcare intelligence and clinical research, has earned multiple prestigious accolades in the first half of 2025, reinforcing its reputation as a…
FDA Approves CorFlow’s MOCA-II IDE Pivotal Trial to Advance Breakthrough Heart Attack Technology CorFlow Therapeutics AG, a Swiss-based medtech innovator specializing in cardiovascular care and microvascular disease, has reached a major milestone in the development of its cutting-edge heart attack…
FDA Approves KalVista’s EKTERLY® as First Oral On-Demand Treatment for Hereditary Angioedema KalVista Pharmaceuticals, Inc. has announced a landmark development in the treatment of hereditary angioedema (HAE): the U.S. Food and Drug Administration (FDA) has officially approved EKTERLY® (sebetralstat), the…
Lubrizol’s Apinovex™ Polymer Honored with Prestigious Pharma Excipients Award at CPhI China 2025 Lubrizol Life Science Health’s Apinovex™ polymer has been awarded a prestigious Celebration Award in the Pharma Excipients Award category at CPhI China 2025, held in Shanghai from…
Ingevity Releases 2024 Sustainability Report, Showcasing Innovation and Commitment to a Greener Future Ingevity Corporation has released its 2024 Sustainability Report, emphasizing the company’s continued dedication to developing innovative technologies and environmentally responsible products that contribute to a more sustainable…
Element Solutions Inc Raises Outlook for Q2 and Full Year 2025 Amid Strong Market Performance Element Solutions Inc (“ESI” or the “Company”), a global diversified specialty chemicals company, today announced an upward revision to both its second quarter and full-year…
Global Biopesticides Market Outlook (2025–2031): Growth Trends, Innovations & Strategic Recommendations The global biopesticides market demonstrated robust growth at a compound annual growth rate (CAGR) of 11.72% between 2021 and 2024, reaching a market value of USD 7.98 billion in…